2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA

Transcription

1 Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity. Acknowledgement of In-Kind Commercial Support No in-kind commercial support was received for this educational activity. Satisfactory Completion Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. Nurses In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Association for the Study of Liver Diseases. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement Amedco LLC designates this live activity for a maximum of 16.0 contact hours for nurses (AASLD/ILTS Transplant Course 5.50 hours, Postgraduate Course 6.75 hours and Hepatology Associates Course 3.75 hours). Learners should claim only the credit commensurate with the extent of their participation in the activity. Nurse Pharmacology Credits Please note onsite agenda for identification of sessions eligible for pharmacotherapeutic hours and self-submit those to your board. Keep the agenda as a reference in case they have questions. Maximum of 14.0 hours. Sessions not eligible for pharmacotherapeutic hours are listed below AASLD/ILTS Transplant Course 1) Perfusion Strategies and Organ Repair (20 minutes) 2) Matching Donors and Recipients to Achieve the Best Outcomes (20 minutes) 3) LDLT vs Deceased Donors (20 minutes) 4) The Contribution of Radiology and Pathology in Transplant Oncology (20 minutes) Hepatology Associates Course 1) Liver Radiology 101 (20 minutes) 2) Evolving Role of Liver Biopsy (20 minutes) Objectives - After attending this program you should be able to: 1. Evaluate recent advancements in groundbreaking basic, translational, comparative effectiveness, outcomes, and clinical research in diseases of the liver and biliary tract that may be readily incorporated into practice.

2 2. Examine short and long-term patient outcomes following liver transplantation by integrating current evidence-based practice in pre-transplant clinical care, advances in surgical techniques, and state-of-the-art post-operative management. 3. Formulate partnerships and develop comparative effectiveness projects, design clinical trials, and complete on-going investigative efforts to improve the health outcomes in acute and chronic diseases of the liver and biliary tract. Disclosure of Conflict of Interest The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS , 6.5) All individuals in a position to control the content of CE are listed below. Hepatology Associates Course Cheryl Dale Program Chair & Moderator Consulting: Abbvie, Lupin, Merck Speakers' Bureau: AbbVie Andrea Gossard Program Chair & Moderator Nothing to Disclose Amanda Chaney Moderator Nothing to Disclose Jeffrey McMahon Moderator Nothing to Disclose Mustafa Bashir Speaker Consulting: RadMD Grant/Research Support: GE Healthcare, Siemens Healthineers, Madrigal Pharmaceuticals, TaiwanJ Pharmaceuticals, NGM Bio John E. Eaton Speaker Advisory Committee or Review Panel: Eli Lilly Anne Croghan Speaker Speaking and Teaching: Gilead, AbbVie, Intercept Robert S. Rahimi Speaker Nothing to Disclose Jody Weckwerth Speaker Nothing to Disclose Romil Saxena Speaker Speaking and Teaching: Targos Inc Robert J. Fontana Speaker Consulting: Alynam Grant/Research Support: abbvie, Gilead, BMS Jasmohan S. Bajaj Speaker Nothing to Disclose ILTS Transplant Course: Expanding the Boundaries for Liver Transplant Oncology Marina Berenguer Program Chair & Moderator Speaking and Teaching: Gilead, MSD, Abbvie, Novartis Roberto Hernandez-Alejandro Program Chair & Moderator Nothing to Disclose Mitra Nadim Program Chair Nothing to Disclose

3 Norah Terrault Speaker Board Membership: HepCareStream Consulting: ADAM Grant/Research Support: Gilead, Merck, BMS, AbbVie, Allergan Miriam Cortes Speaker Nothing to Disclose Nazia Selzner Speaker Nothing to Disclose Markus Selzner Speaker Nothing to Disclose Simone I Strasser Speaker Advisory Committee or Review Panel: Bayer, Eisai, Bristol-Myers Squibb, Astellas, AbbVie, Gilead, MSD Speaking and Teaching: Bayer, AbbVie, Novartis Susan L. Orloff Speaker Nothing to Disclose Laura M. Kulik Speaker Consulting: BMS, Bayer, Easai, BTG Neil Mehta Speaker Nothing to Disclose Julie Heimbach Speaker Nothing to Disclose Vincenzo Mazzaferro Speaker Speaking and Teaching: Terumo, IPSEN, EASL Yuri Genyk Speaker Nothing to Disclose Svein Dueland Speaker Nothing to Disclose Gonzalo Sapisochin Speaker Nothing to Disclose Bijan Eghtesad Speaker Grant/Research Support: Sanofi Elizabeth Pomfret Speaker & Moderator Advisory Committee or Review Panel: Astellas Board Membership: Donor Alliance Kymberly Watt Speaker Grant/Research Support: Gilead, Intercept Richard Finn Speaker Advisory Committee or Review Panel: Astra Zeneca Consulting: Bayer, Bristol Myers Squibb, Eisai, EliLilly, Merck, Pfizer Kathryn Fowler Speaker Nothing to Disclose Valerie Paradis Speaker Nothing to Disclose Postgraduate Course: A Hectic Day for a Hepatology Consultant Michael Fried Program Chair Consulting: AbbVie, BMS, Merck, TARGET PharmaSolutions Grant/Research Support: AbbVie, BMS, Gilead, Merck, NIH Stock/Stock Options: TARGET PharmaSolutions (held in an independently managed trust.) Cynthia Levy Program Chair Consulting: Intercept, Novartis, TARGET PharmaSolutions, GSK Royalties: Up-To-Date Advisory Committee or Review Panel: Intercept Grant/Research Support: Intercept, Gilead, GSK, NGM, Tobira, Novartis, Genfit, CymaBay, Shionogi Tse-Ling Fong Program Chair Nothing to Disclose

4 Naga Chalasani Moderator Consulting: Cumberland, Axovant, Immuron, Madrigal, Shire, NuSirt, Allergan, Abbvie Grant/Research Support: Galectin, Intercept Rohit Loomba Moderator Grant/Research Support: Gilead, Merck, Intercept, NuSirt, Genfit, Promedior, Kinemed, Adheron, Allergan, Immuron, Galmed, Intercept, Arisaph, Shire, BMS, Galectin, Immuron, NGM, Siemens, Eli Lilly, GE, Octeta, Inc Consulting: Gilead, Novo Nordisk, Pfizer, BMS, NGM, Celgene, Boehringer Ingelheim, Eli Lilly, Ionis, Metacrine, CohBar, Bird rock bio, Intercept, GNI, GRI, Glympse bio, Conatus, Alergan, Cymabay and Janssen Inc. Advisory Committee or Review Panel: Gilead, Galmed, Intercept, Gemphire, Arrowhead Research, Second Genome, Median Technologies, Conatus, Octeta Patent Held/Filed: LipoNexus Inc Alfred Sidney Barritt IV Speaker Advisory Committee or Review Panel: Target PharmasolutionsConsulting: Dova PharmaceuticalsSpeaking and Teaching: SC Liver Research Consortium Michael P. Manns Speaker Advisory Committee or Review Panel: Gilead, Novartis, Abbvie, MSD - Merck Sharp & Dome Speaking and Teaching: Falk Foundation Heiner Wedemeyer Speaker Advisory Committee or Review Panel: Norgine, MSD, Janssen, Roche Diagnostic Board Membership: Gilead, Abbvie Consulting: Eiger, MyrGmbH, Abbott, BMS Grant/Research Support: Gilead, Roche Diagnsotics, Abbott, BMS Speaking and Teaching: Gilead, Falk, Norgine, MSD, Abbvie, Abbott, BMS Mandana Khalili Speaker Grant/Research Support: Gilead Sciences, Intercept Pharmaceuticals Guadalupe Garcia-Tsao Moderator Advisory Committee or Review Panel: BioVie, Conatus, Cook, Exalenz, Genfit, Grifols, Intercept Consulting: Conatus, Galectin Oren Fix Moderator Nothing to Disclose Kymberly Watt Speaker Grant/Research Support: Gilead, Intercept Andres Cardenas Speaker Board Membership: Liver Transplantation Journal Consulting: UptoDate Grant/Research Support: Boston Scientific Steven L. Flamm Speaker Consulting: Gilead, Abbvie, Merck, Salix, Intercept, Dova, Shonogi Grant/Research Support: Gilead, Abbvie, Intercept Rajiv Jalan Speaker Consulting: Yaqrt Ltd Grant/Research Support: Ocera Therapeutics Inc. Vijay Shah Speaker Advisory Committee or Review Panel: Novartis Pharmaceuticals, Merck Research Laboratories, Afimmune, Ltd, Durect Corporation Laura Kulik Moderator Consulting: BMS, Bayer, Easai, BTG K Rajender Reddy Moderator Advisory Committee or Review Panel: Abbvie,, Merck, Gilead Consulting: Novartis Grant/Research Support: Abbvie-Paid to the University of Pennsylvania, Merck-paid to the

5 University of Pennsylvania, Gilead-paid to the University of Pennsylvania, Conatus-paid to the University of Pennsylvania, Mallinckrodt-paid to the University of Penn Christopher L. Bowlus Speaker Advisory Committee or Review Panel: Contatus, BMSGrant/Research Support: Intercept Pharmaceuticals, Cymabay, Gilead, Arena, GSK, NGM Bio, Takeda, Genkyotex, JKB Taiwan, TARGET Pharmasolutions Paul Yien Kwo Speaker Advisory Committee or Review Panel: BMS, Gilead, Merck, Shionogi, Dova, Durect, Janssen, Abbvie Grant/Research Support: Abbvie, Gilead, Aurora, La Jolla Pharmaceuticals Speaking and Teaching: Merck Stock Shareholder: Durect Lewis R. Roberts Speaker Advisory Committee or Review Panel: Bayer, Exact Sciences, TAVEC, Inc Grant/Research Support: Gilead Sciences, Wake Diagnostics, Ariad Pharmaceuticals, BTG International, RedHill BioPharma Paul C. Adams Speaker Consulting: Protagonist Therapeutics Mindie H Nguyen Speaker Advisory Committee or Review Panel: Gilead Consulting: Norvatis, Spring Bank Grant/Research Support: B K Kee Foundation, Gilead, NCI Kimberly Brown Moderator Grant/Research Support: AbbVie, Gilead, Duke Research Institute, Novartis, Allergan; Expert Testimony: Simply Speaking CME; Advisory Board: AbbVie, BMS, Gilead, Merck, Janssen Estella Alonso Moderator Nothing to Disclose Nancy Reau Speaker Nothing to Disclose Keyur Patel Speaker Advisory Committee or Review Panel: Gilead Sciences, Merck Michael B. Fallon Speaker Nothing to Disclose Elizabeth Rand Speaker Nothing to Disclose Patrick S. Kamath Speaker Nothing to Disclose How to get your certificate: 1. Go to 2. Click on the 2018 Annual Liver Meeting link 3. Evaluate the conference Please print all pages of your certificate for your record. Questions? Certificate@Amedco .com